Remove Pharmaceuticals Remove Pharmacy Remove Production
article thumbnail

India’s Growing Importance in Generic Drug API Manufacturing

Drug Patent Watch

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

article thumbnail

Pharmacognosy and Drug Patents: Unveiling Nature’s Medicinal Treasures

Drug Patent Watch

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. What is a Drug Patent?

Drugs 93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Four Solutions Manufacturers Should Consider For Retail and Specialty-lite Products

Drug Channels

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment.

article thumbnail

Informa Connect’s Hub and Specialty Pharmacy Models East

Drug Channels

Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. Attorney’s Office, District of New Jersey Lauren Powell, MPA, PhD, Vice President, US Health Equity & Community Wellness, Takeda Pharmaceuticals PLUS! Attorney, U.S.

article thumbnail

Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules

Drug Channels

In todays fast-moving pharmaceutical marketplace, insight is everything. Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. pharmaceutical distribution.

article thumbnail

Informa Connect’s Trade and Channel Strategies

Drug Channels

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

article thumbnail

White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)

Drug Channels

However, provider pushback has limited specialty pharmacies' share gains, so that buy-and-bill remains the most common channel for these products. Payers adoption of white baggingand providers push backreflect the ongoing battle for oncology margin in U.S. drug channels. drug channels.